⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Uncategorized Published - 3 June, 2020    By - Dr Clemens
Thromboelastographic Assessment of Fibrinolytic Activity in Postpartum Hemorrhage

AUTHORS: Arnolds, David E. MD, PhD et al *; Scavone, Barbara M. MD*,† Anesthesia & Analgesia: April 2020 BACKGROUND: Postpartum hemorrhage is a leading cause of maternal mortality. Antifibrinolytic therapy has the potential to influence outcomes in postpartum hemorrhage, but the incidence of elevated fibrinolytic activity in postpartum hemorrhage is unknown. METHODS: We retrospectively reviewed […]

Read More
Uncategorized Published - 3 June, 2020    By - Dr Clemens
How the COVID-19 pandemic is traumatizing health care professionals

Author: Rebecca Elia MD KevinMD.com Many of us (especially psychiatrists and physician coaches) have been warning the medical profession at large for weeks now that we are headed for unprecedented numbers of physicians, nurses, other health care workers, and first responders suffering from PTSD. A free support group of psychiatrists for physicians formed rapidly. Several […]

Read More
Uncategorized Published - 3 June, 2020    By - Dr Clemens
Adding to the Tool Chest: Virtual Visits for Chronic Pain

Author: Tony Mira F1rst News                                                                        Summary Pain practitioners are in a unique position to utilize the new waivers and changes […]

Read More
Uncategorized Published - 3 June, 2020    By - Dr Clemens
U.S. awards new $628 million contract to boost output of potential COVID-19 vaccine

Author: Vishwadha Chander Reuters The U.S. government on Monday entered into a $628 million contract with drugmaker Emergent BioSolutions (EBS.N) to boost manufacturing capacity for a potential COVID-19 vaccine. As drugmakers race to develop vaccines, tests and therapies for the disease, the United States is looking to secure manufacturing capacity under its “Operation Warp Speed” […]

Read More
Uncategorized Published - 3 June, 2020    By - Dr Clemens
Remdesivir most beneficial in COVID-19 patients who require supplemental oxygen

DG Alerts The US National Institutes of Health (NIH) announced that preliminary results from the Adaptive COVID-19 Treatment (ACTT) trial, testing remdesivir in hospitalised adults with COVID-19 who have generally moderate-to-severe disease, indicate that the experimental antiviral was most beneficial in those who required supplemental oxygen. Early data from the trial, which have now been published in […]

Read More